Other OTC Healthcare Products Market in Ireland to 2014 (OTC Healthcare)

Introduction

This databook provides key data and information on the Other OTC Healthcare Products Market in Ireland (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

*Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
*Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights


Other OTC healthcare products category was valued at €39.7m ($58.1m) in 2009, representing a CAGR of 4.1% since 2004.

By the end of 2014, other OTC healthcare products category will be worth €45.5m ($66.7m), with an expected CAGR of 2.8% between 2009 and 2014.

Other OTC healthcare products market was led by anti-smoking aids (representing 59% of the total value) followed by rectal medications and eye / ear drops, with a 14.7% and 14.1% market share, respectively. Sleeping aids and motion sickness constitute the remaining segments with a 10.4% and 1.8% market share, respectively.

GlaxoSmithKline Plc is the market leader with a 22.3% share of the market.


Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in Ireland (OTC Healthcare)

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: other OTC healthcare products 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Other OTC Healthcare Products 8
Value analysis (Euro), 2004?09 8
Value analysis (Euro), 2009?14 9
Value analysis (US dollars), 2004?09 11
Value analysis (US dollars), 2009?14 12
Company and brand share analysis 14
Distribution analysis 18
Chapter 4 Macroeconomic Profile 20
Macroeconomic indicators 20
Chapter 5 Research Methodology 25
Methodology overview 25
Secondary research 26
Market modeling 27
Creating an initial data model 27
Revising the initial data model 27
Creating a final estimate 28
Creating demographic value splits 28
Primary research 28
Data finalization 29
Ongoing research 29

LIST OF FIGURES
Figure 1: Other OTC healthcare products, Ireland, value by segment (€m), 2004?14 10
Figure 2: Other OTC healthcare products, Ireland, category growth comparison, by value, 2004?14 13
Figure 3: Other OTC healthcare products, Ireland, company share by value (%), 2008?09 16
Figure 4: Other OTC healthcare products, Ireland, distribution channels by value (%), 2008?09 19
Figure 5: Annual data review process 26

LIST OF TABLES
Table 1: Other OTC health care products category definitions 3
Table 2: Other OTC health care products distribution channels 4
Table 3: Other OTC healthcare products, Ireland, value by segment (€m), 2004?09 8
Table 4: Other OTC healthcare products, Ireland, value forecast by segment (€m), 2009?14 9
Table 5: Other OTC healthcare products, Ireland, value by segment ($m), 2004?09 11
Table 6: Other OTC healthcare products, Ireland, value forecast by segment ($m), 2009?14 12
Table 7: Other OTC healthcare products, Ireland, brand share by value (%), 2008?09 14
Table 8: Other OTC healthcare products, Ireland, value by brand (€m), 2008?09 15
Table 9: Other OTC healthcare products, Ireland, company share by value (%), 2008?09 17
Table 10: Other OTC healthcare products, Ireland, value by company (€m), 2008?09 17
Table 11: Other OTC healthcare products, Ireland, distribution channels by value (%), 2008?09 18
Table 12: Other OTC healthcare products, Ireland, value by distribution channel (€m), 2008?09 18
Table 13: Ireland population, by age group, 2004?09 (millions) 20
Table 14: Ireland population forecast, by age group, 2009?14 (millions) 21
Table 15: Ireland population, by gender, 2004?09 (millions) 21
Table 16: Ireland population forecast, by gender, 2009?14 (millions) 22
Table 17: Ireland nominal GDP, 2004?09 (€bn, nominal prices) 22
Table 18: Ireland nominal GDP forecast, 2009?14 (€bn, nominal prices) 22
Table 19: Ireland real GDP, 2004?09 (€bn, 2000 prices) 23
Table 20: Ireland real GDP forecast, 2009?14 (€bn, 2000 prices) 23
Table 21: Ireland real GDP, 2004?09 ($bn, 2000 prices) 23
Table 22: Ireland real GDP forecast, 2009?14 ($bn, 2000 prices) 24
Table 23: Ireland consumer price index, 2004?09 (2000=100) 24
Table 24: Ireland consumer price index, 2009?14 (2000=100) 24


[Inhaltsverzeichnis ausblenden]